KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Onyx BioLabs: 34 Kovera certificates.
The lab's record shows 34 certificates printed for Onyx BioLabs, analysed between 27 Mar 2026 and 21 May 2026, covering 16 products. Median HPLC purity is 99.92%. Kovera graded 34 as a pass and 0 as a fail.
34
certificates
99.92%
median purity
16
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 34 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 18 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
16 AS PRINTEDRetatrutide · 11BPC-157/TB-500 · 4BPC-157 · 2GHK-Cu · 2MOTS-c · 2Selank · 2Tesamorelin · 2CJC-1295 (No DAC)/Ipamorelin · 1Glow · 1IGF-1 LR3 · 1Ipamorelin · 1Kisspeptin-10 · 1Klow · 1KPV · 1PT-141 · 1Semax · 1
Every certificate
NEWEST FIRST · 34 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-787A84 | Retatrutide | RET15-26051A | 98.668% | 101.4%15.21 of 15 mg | 21 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4878D9 | Retatrutide | RET30-26051A | 99.664% | 110.5%33.15 of 30 mg | 21 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-44D281 | Retatrutide | RET10-26051A | 99.368% | 101.5%10.15 of 10 mg | 21 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FF768C | Retatrutide | RET40-26051A | 98.771% | 107.7%43.06 of 40 mg | 20 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-ECE628 | Glow | GLOW0526-70-1 | 99.714% | 110.7%77.52 of 70 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BBF541 | Tesamorelin | TES20-260312A | 99.943% | 117.7%23.54 of 20 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B35951 | Selank | SEL-0526-10A | 99.948% | 106.3%10.63 of 10 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-AD0E47 | Retatrutide | RETA0526-5A | 99.893% | 116.2%5.81 of 5 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7F3B1A | BPC-157 | BPC0925-5-1 | 99.816% | 115.2%5.76 of 5 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-73DF70 | Kisspeptin-10 | KIS10-260323A | 99.899% | 107.9%10.79 of 10 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4B05FD | BPC-157 | BPC0925-10-1 | 99.853% | 110.1%11.01 of 10 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3B7431 | BPC-157/TB-500 | BPT-2026-0310 | 99.777% | 108.9%10.89 of 10 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2D54FB | BPC-157/TB-500 | BPT-20-0526 | 99.719% | 104.0%20.81 of 20 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2AE929 | PT-141 | PT110-260323A | 99.916% | 105.8%10.58 of 10 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2A53BE | MOTS-c | MC-052026A | 99.924% | 113.4%45.37 of 40 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-291DA3 | Tesamorelin | TES10-260312A | 99.852% | 118.2%11.82 of 10 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-118A1B | Retatrutide | RETA0526-20-1 | 99.866% | 105.5%21.11 of 20 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-04397F | KPV | KPV0126-10-1 | 99.957% | 116.3%11.63 of 10 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-FD8455 | Selank | SEL-2026-0320 | 99.934% | 114.3%11.43 of 10 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-EFFC34 | GHK-Cu | GHK0925-50-1 | 99.951% | 109.7%54.83 of 50 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B49FB3 | Ipamorelin | IPA-2026-0320 | 99.938% | 118.1%11.81 of 10 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B3A088 | Retatrutide | RET10-260312A | 99.948% | 140.2%14.02 of 10 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-808A81 | MOTS-c | MOTSC1025-40-1 | 99.933% | 108.7%43.47 of 40 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-7811C6 | Retatrutide | RET20-260312A | 99.947% | 109.8%21.97 of 20 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-633D19 | BPC-157/TB-500 | BPCT0925-10-1 | 99.689% | 115.0%11.5 of 10 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-489796 | Retatrutide | RETA0326-40-1 | 99.976% | 104.8%41.91 of 40 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-469B00 | BPC-157/TB-500 | BPT-2026-0320 | 99.787% | 112.2%22.45 of 20 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-459276 | GHK-Cu | GHK0925-100-1 | 99.978% | 109.6%109.58 of 100 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-412C92 | CJC-1295 (No DAC)/Ipamorelin | CJI0126-10-1 | 99.963% | 115.6%11.56 of 10 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3D9E9C | IGF-1 LR3 | IGF-2026-0320 | 99.923% | 108.0%1.08 of 1 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1FAD9A | Retatrutide | RETA0925-5-1 | 99.942% | 130.4%6.52 of 5 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0841A6 | Klow | KLO80-260312A | 99.882% | 112.3%89.82 of 80 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-066A44 | Retatrutide | RETA0126-30-1 | 99.946% | 96.1%28.84 of 30 mg | 27 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-055AB1 | Semax | SEM-2026-0320 | 99.942% | 111.4%11.14 of 10 mg | 27 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |